Amotio
Founded 2023 · 3 employees on LinkedIn · 4 known investors
Find your way into Amotio
13 people in our graph share verified history with the Amotio team — schools, employers, funds. One of them is your warm intro.
Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.
Founders & leadership
Amotio was founded in 2023 by Iestyn Foster.

Investors · 4
How we know: the company's own site · funding news · press coverage · Not right? Tell us
How we know: NLC's portfolio page · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seed funding roundJul 2025
Development Bank of Wales (lead), NLC Health Ventures, Orthopaedic Research UK (ORUK)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Amotio do?
- Amotio develops a guided bone cement removal system with patient-specific surgical planning and precision instrumentation for orthopaedic revision surgery, targeting arthroplasty and revision surgeons who work with cemented joint implants. The medical device company, based in the Netherlands and Wales, is preparing for US commercial launch in the revision arthroplasty market.
- Who founded Amotio?
- Amotio was founded by Iestyn Foster in 2023.
- Who are Amotio's investors?
- Amotio's investors include Development Bank of Wales, NLC.

